IDYA CIK: 1676725

IDEAYA Biosciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.25
FY22:
0.37
FY23:
0.53
FY24:
0.69
FY25:
0.67
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.13
FY22:
0.02
FY23:
0.12
FY24:
0.43
FY25:
0.44
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.38
FY22:
0.39
FY23:
0.65
FY24:
1.12
FY25:
1.11

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.05
FY22:
0.03
FY23:
0.03
FY24:
0.05
FY25:
0.06
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.03
FY22:
0.01
FY23:
0.00
FY24:
0.02
FY25:
0.03
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.30
FY22:
0.35
FY23:
0.62
FY24:
1.06
FY25:
1.02
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.38
FY22:
0.39
FY23:
0.65
FY24:
1.12
FY25:
1.11

All amounts in billions USD Data source:SEC EDGAR